KEY FINDINGS The North America hydrogel market is expected to grow with a CAGR of 5.66%, across the forecast period of 2019 to 2028. The key factors driving market growth include the rising aging population, wound management, and the surging incidence of chronic diseases like eye disorders and diabetes.
MARKET INSIGHTS The North America hydrogel market growth is analyzed through the United States and Canada.As Canada’s geriatric population continues to increase, the country’s universal healthcare system is projected to need comprehensive amendments to acknowledge the persistent demands of wound management.
Besides, advanced wound dressings in Canada are not subject to strict pricing guidelines and regulations, when compared to other medical products.As a result, the nation fosters some of the highest medical expenses for advanced wound care dressing.
Additionally, growing investments in research and development facilities for launching innovative products is anticipated to generate lucrative business and growth opportunities in Canada.The rising incidence of healthcare expenditure in bolsters the demand for personal care and contact lenses, as well.
The provincial governments also play a substantial role in bearing financial responsibilities for funding healthcare services, in addition to other public programs like social services and education. Moreover, the rising awareness regarding health and the advantages of natural and organic beauty products have transformed young citizens’ lifestyles. Also, the increasing popularity of organic beauty products and their easy availability through diverse e-commerce portals and online retailers have facilitated the market growth for hydrogels.
COMPETITIVE INSIGHTS Some of the eminent players in the market are Ashland North America Holdings Inc, Essity, Paul Hartman, Cardinal Health, Smith & Nephew, etc.
Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned 1. ASHLAND NORTH AMERICA HOLDINGS INC 2. B BRAUN HOLDING GMBH &CO KG 3. CARDINAL HEALTH 4. ESSITY 5. MEDLINE INDUSTRIES INC 6. PAUL HARTMAN 7. PROCYON CORPORATION 8. SMITH & NEPHEW 9. THE COOPER COMPANIES 10. 3M COMPANY 11. JOHNSON & JOHNSON 12. ROYAL DSM 13. MEDTRONIC PLC 14. DOW CORNING 15. MOMENTIVE PERFORMANCE MATERIALS 16. DERMA SCIENCES 17. COLOPLAST 18. HOYA CORPORATION 19. INTEGRA LIFESCIENCES 20. ALCON (NOVARTIS AG)
Our reports have been used by over 10K customers, including:
The North America Hand Sanitizer market is projected to grow at a CAGR of 3.06% during the forecast period (2020 - 2025). - Conventionally dragged by general consumer awareness regarding hand hygiene, sanitizers today have witnessed an upsurge delivered by global pandemic that is COVID 19, serving the primary factor driving regional...
Inspection Machine Market Research Report by Product (Check Weigher, Metal Detector, Software, and Vision Inspection), by Type (Automatic and Manual), by Packaging, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major...
Medical Device Security Market Research Report by Component (Services and Solutions), by Device Type (Embedded Medical Devices, Hospital Medical Devices, and Wearable Medical Devices), by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast...
Medical Packaging Films Market Research Report by Type (Co-extruded Films, Formable Films, and High Barrier Film), by Material (Polyamide, Polyethylenes, Polypropylene, and Polyvinyl Chloride), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing...
Animal Disinfectants Market Research Report by Type (Chlorine, Chlorine Dioxide, Chlorohexidine, Glut-Quat Mixes, and Glycolic Acid), by Form (Liquid and Powder), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five...
Bioburden Testing Market Research Report by Product (Consumables and Instruments), by Test (Aerobic Count Testing, Anaerobic Count Testing, Fungi/Mold Count Testing, and Spore Count Testing), by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides...
Biophotonics Market Research Report by Application (Biosensors, Inside Imaging, Light Therapy, Microscopy, and Other Analytics Sensing), by End-Use (Medical diagnostics, Medical therapeutics, Non-medical application, and Tests and components) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Bovine Serum Albumin Market Research Report by Preparation Method (Cold Ethanol Fractionation, Heat Shock Fractionation, Ion Exchange Chromatography, and Membrane Filtration), by Grade (Food-Grade, Reagent- /Research-Grade, and Technical- & Diagnostic-Grade), by Form, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the vascular endothelial growth factor (VEGF) inhibitor market are Pfizer, Amgen, Roche, Xbrane Biopharma AB, Genentech Inc., AstraZeneca plc, Bayer AG, Eli Lilly and Company and Allergan plc. The global vascular endothelial growth factor (VEGF) inhibitor market is expected to decline from $0.31 billion in 2019 to $0.28...